Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
05/2001
05/17/2001WO2001034573A1 Compounds
05/17/2001WO2001034551A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
05/17/2001WO2001034127A1 Prevention of plaque rupture by acat inhibitors
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001CA2382676A1 Prevention of plaque rupture by acat inhibitors
05/16/2001CN1295560A C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/09/2001EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction
05/09/2001EP1097707A1 Treatment of female sexual dysfunction
05/09/2001EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
05/09/2001EP0633776B1 Compounds useful for treating allergic and inflammatory diseases
05/09/2001CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/03/2001WO2001031110A1 Low odor, hard surface abrasive cleaner with enhanced soil removal
05/02/2001EP1095031A1 Antiviral macrocyclic compounds
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP0882010B1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6225074 Mixing test sample with reagent solution of chloramphenicol or derivative, an acyl coenzyme a compound, and a tetrazolium salt, then observing optical response; solution does not contain redox enzyme
04/2001
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1093819A2 Compounds and compositions for delivering active agents
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/19/2001WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
04/18/2001EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/18/2001CN1064679C Herbicidal thiocarbamoyltetrazolinones
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001CN1291184A Cycloalkene derivatives, process for producing the same and use
04/11/2001CN1064355C Microcyclic chelants their chelates and uses thereof in the diagnostic field
04/11/2001CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives
04/10/2001US6214999 A brominating agent is reacted in a 2 phase medium, under effect photo-irradiation with biphenyl derivative
04/10/2001US6214988 By providing a granule comprising alpha-hmx (1,3,5,7-tetranitro-1,3,5,7-tetraazacyclooctane) particles and which has internal void spaces, and sorbing at least one second material into the void spaces; making shaped article
04/10/2001US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia
04/10/2001US6214877 Antidiabetic agents; modulator of glucose concentration
04/10/2001US6214850 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
04/10/2001CA2051883C Alkoxybenzotriazole compositions and the use thereof as copper and copper alloy corrosion inhibitors
04/05/2001WO2001023347A1 Novel aromatic compounds
04/04/2001EP1087953A1 Nitrate salts of antihypertensive medicines
04/04/2001EP1087943A1 Therapeutic biaryl derivatives
04/04/2001CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas
04/03/2001US6211234 Substituted phenyl compounds
04/03/2001US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction
04/03/2001US6211175 Cardiac diseases improving method
03/2001
03/28/2001EP1086063A1 Novel potassium channel drugs and their uses
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/27/2001US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion
03/21/2001CN1063430C Ethanolamine derivatives
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204292 Bicyclic metabotropic glutamate receptor ligands
03/20/2001US6204259 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
03/15/2001WO2000053583A8 Inhibitors of protein tyrosine phosphatase
03/14/2001EP1082299A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
03/14/2001EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001CN1286254A Aromatic amino ether as analgesics
03/06/2001US6197993 Prostaglandin e2 antagonists or agonists
03/06/2001US6197958 Carboxylic acid derivatives, their preparation and use
03/06/2001US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/01/2001WO2001014346A1 Macrocyclic compounds and preparation methods thereof
02/2001
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/28/2001EP1078033A1 Metal ligand containing bleaching compositions
02/28/2001EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
02/28/2001EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
02/28/2001CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition
02/28/2001CN1285350A 1-cyclenes tetraazolelinketone and the like
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/27/2001US6194425 Viricides, antitumor agents
02/22/2001WO2001012612A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001CA2381090A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/21/2001CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis
02/21/2001CN1284944A Integrin receptor antagonists
02/20/2001US6191289 Production process and intermediate of tetrazole compound
02/20/2001US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
02/20/2001CA2084036C Use of specific counteranions to modify the solubility of tetrazolium salts
02/15/2001WO2001010850A1 Herbicidal tetrazolinone derivatives
02/15/2001WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives
02/15/2001CA2381532A1 Herbicidal tetrazolinone derivatives
02/15/2001CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives
02/14/2001CN1283617A Terazololine-one
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 97